Loading insider details...
Latest Form 4 (Sep 30, 2026): Grant/Award of 642 RPRX shares, $37.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 642 | $37.5K |
| Jun 30, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 689 | $37.5K |
| Jun 8, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 4,545 | n/a |
| Mar 31, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 815 | $37.5K |
| Jan 8, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,500 | $561.2K |
| Jan 8, 2026 | Cidara Therapeutics, Inc. (CDTX) | Disposition to Issuer | 15 | $3.3K |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 2, 2026 | Royalty Pharma plc (RPRX) | Grant/Award | 967 | $37.5K |
| Nov 24, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 760 | $282.3K |
| Sep 30, 2025 | Royalty Pharma plc (RPRX) | Grant/Award | 1,047 | $37.5K |